高级检索
    朱广迎, 于会明, 郑明英. 克唑替尼与化疗在ALK阳性晚期非小细胞肺癌颅内疾病控制率的比较[J]. 循证医学, 2016, 16(4): 218-221. DOI: 10.12019/j.issn.1671-5144.2016.04.009
    引用本文: 朱广迎, 于会明, 郑明英. 克唑替尼与化疗在ALK阳性晚期非小细胞肺癌颅内疾病控制率的比较[J]. 循证医学, 2016, 16(4): 218-221. DOI: 10.12019/j.issn.1671-5144.2016.04.009
    shu
    ZHU Guang-ying, YU Hui-ming, ZHENG Ming-ying. Intracranial Efficacy of Crizotinib Versus Chemotheropy in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(4): 218-221. DOI: 10.12019/j.issn.1671-5144.2016.04.009
    Citation: ZHU Guang-ying, YU Hui-ming, ZHENG Ming-ying. Intracranial Efficacy of Crizotinib Versus Chemotheropy in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(4): 218-221. DOI: 10.12019/j.issn.1671-5144.2016.04.009
    shu

    克唑替尼与化疗在ALK阳性晚期非小细胞肺癌颅内疾病控制率的比较

    Intracranial Efficacy of Crizotinib Versus Chemotheropy in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(11)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回